![Minter Hormone Health wins Femtech and Women’s Health competition](/sites/default/files/2024-07/Minter%20Hormone%20Health%20wins%20Femtech%20and%20Women%E2%80%99s%20Health%20competition.png)
Minter Hormone Health wins Femtech and Women’s Health competition
Discovery Park has announced Minter Hormone Health as the winner of the Discovery Spark FemTech and Women’s Health Prize, following a rigorous pitch process evaluated by three expert panels.
This victory awards the Women’s Health startup a prize package valued at over £50,000, which includes a year of lab or office space at Discovery Park, along with comprehensive support from specialist prize partners.
Discovery Park, a dynamic life science and innovation hub, is dedicated to fostering organisations that are revolutionising women’s health. This announcement concludes the seven-week Discovery Spark programme, which saw 11 promising companies participating in sessions at Discovery Park in Sandwich. The programme equipped early-stage businesses with the skills needed for successful investment pitches, covering topics such as team building, branding, presentation, communication, and business metrics.
Minter Hormone Health, founded by nurse Lexie Minter, is a healthcare provider specialising in personalised care for women dealing with perimenopause, menopause, PCOS, endometriosis, and other reproductive health needs. The company offers consultations and hormone health services across the UK through a virtual platform and in-person clinics in London and Kent. Each patient receives a customised service, including bespoke hormone replacement therapies, tailored to their unique needs and medical history.
Lexie Minter, founder of Minter Hormone Health, said: “Empowering women is fundamental to what we do and our patients value the exceptional service they receive in our clinics. We aim to roll-out our high level of expert care across the UK via a network of women’s health hubs that will be accessible to all. We must engage with women who are underserved and whose needs are not met by the current healthcare system. We will invest in research and change the future of women's health for all, not just the few.”
“The Discovery Spark programme has been hugely rewarding and insightful. We are thrilled to be recognised with this award and the prize package brings us one step closer to our goal of improving healthcare outcomes, delivering female-centred care based on women’s unique physiology and ensuring equitable treatment for all.”
Dr Renos Savva, Programme Lead and Head of Innovation and Venture Development at Discovery Park, said: “We had an exceptional cohort for our FemTech and Women’s Health programme, reflecting the strength of companies working tirelessly to close the gender health gap. A massive congratulations to Minter Hormone Health, as the competition was fierce, with just four points between the top five. Discovery Spark exists to champion early-stage businesses, and I’m immensely proud of the strides made by this group.”
The drill pitch session was held on 4th July and included keynote speeches from Wendy Powell CEO, Mutu, a leading global digital health platform clinically recommended for perinatal pelvic health, and Juliet Gouldman, Head of Strategic and External Engagement at Barclays.
The FemTech and Women’s Health Discovery Spark Drill Pitch Day was contested by 8 (listed alphabetically) of the 11 companies from the programme: BodyOwn, Cooden Cosmetics, Cyril Protect, imphatec Ltd, Minter Hormone Health, Pelvity, S.M. Discovery Group (SMDG), and Young Mums Support Network.